Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections

被引:1
|
作者
Zeng, Juan [1 ]
Leng, Bing [2 ]
Guan, Xiaoyan [1 ]
Jiang, Shuangyan [1 ]
Xie, Maoyu [3 ]
Zhu, Wenying [1 ]
Tang, Yue [1 ]
Zhang, Lin [1 ]
Sha, Jing [1 ]
Wang, Tengfei [1 ]
Ding, Min [1 ]
Guo, Nan [2 ]
Jiang, Jinjiao [1 ]
机构
[1] Shandong First Med Univ, Dept Crit Care Med, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
[2] Shandong First Med Univ, Dept Pharm, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Dept Emergency, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
polymyxin B; pharmacokinetics; elderly; critical care; total body weight; renal function;
D O I
10.3389/fphar.2024.1347130
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Elderly patients are more prone to develop acute kidney injury during infections and polymyxin B (PMB)-associated nephrotoxicity than young patients. The differential response to PMB between the elderly and young critically ill patients is unknown. We aimed to assess PMB exposure in elderly patients compared with young critically ill patients, and to determine the covariates of PMB pharmacokinetics in critically ill patients. Methods: Seventeen elderly patients (age >= 65 years) and six young critically ill patients (age < 65 years) were enrolled. Six to eight blood samples were collected during the 12 h intervals after at least six doses of intravenous PMB in each patient. PMB plasma concentrations were quantified by high-performance liquid chromatography-tandem mass spectrometry. The primary outcome was PMB exposure as assessed by the area under the concentration-time curve over 24 h at steady state (AUC(ss, 0-24 h)). Results and Discussion: The elderly group had lower total body weight (TBW) and higher Charlson comorbidity scores than young group. Neither AUC(ss, 0-24 h) nor normalized AUC(ss, 0-24 h) (adjusting AUC for the daily dose in mg/kg of TBW) was significantly different between the elderly group and young group. The half-life time was longer in the elderly patients than in young patients (11.21 vs 6.56 h respectively, p = 0.003). Age and TBW were the covariates of half-life time (r = 0.415, p = 0.049 and r = -0.489, p = 0.018, respectively). TBW was the covariate of clearance (r = 0.527, p = 0.010) and AUC(ss, 0-24 h) (r = -0.414, p = 0.049). Patients with AUC(ss, 0-24 h) >= 100 mg<middle dot>h/L had higher baseline serum creatinine levels and lower TBW than patients with AUC(ss, 0-24 h) < 50 mg<middle dot>h/L or patients with AUC(ss, 0-24 h) 50-100 mg<middle dot>h/L. The PMB exposures were comparable in elderly and young critically ill patients. High baseline serum creatinine levels and low TBW was associated with PMB overdose.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Treatment of multidrug-resistant Gram-negative bloodstream infections in critically ill patients: an update
    Viasus, Diego
    Gudiol, Carlota
    Carratala, Jordi
    CURRENT OPINION IN CRITICAL CARE, 2024, 30 (05) : 448 - 455
  • [42] Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria
    Velkov, Tony
    Gallardo-Godoy, Alejandra
    Swarbrick, James D.
    Blaskovich, Mark. A. T.
    Elliott, Alysha G.
    Han, Meiling
    Thompson, Philip E.
    Roberts, Kade D.
    Huang, Johnny X.
    Becker, Bernd
    Butler, Mark S.
    Lash, Lawrence H.
    Henriques, Sonia Troeira
    Nation, Roger L.
    Sivanesan, Sivashangarie
    Sani, Marc-Antoine
    Separovic, Frances
    Mertens, Haydyn
    Bulach, Dieter
    Seemann, Torsten
    Owen, Jeremy
    Li, Jian
    Cooper, Matthew A.
    CELL CHEMICAL BIOLOGY, 2018, 25 (04): : 380 - +
  • [43] The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli
    Zhao, Jiang-nan
    Zhang, Xian-xin
    He, Xiao-chun
    Yang, Guo-ru
    Zhang, Xiao-qi
    Li, Huai-chen
    PLOS ONE, 2015, 10 (07):
  • [44] Polymyxin B Consumption and Incidence of Gram-Negative Bacteria Intrinsically Resistant to Polymyxins
    Falci, Diego R.
    Pacheco, Liliane S.
    Puga, Luciana S.
    da Silva, Renato C. F.
    Alves, Anelise P.
    Behar, Paulo R. P.
    Zavascki, Alexandre P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (05): : 536 - 537
  • [45] CHARACTERISTICS OF AEROBIC GRAM-NEGATIVE BACTERIA COLONIZING CRITICALLY ILL PATIENTS
    DONALDSON, SG
    AZIZI, SQ
    DALNOGARE, AR
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (01): : 202 - 207
  • [46] PATHOGENESIS AND PREVENTION OF NOSOCOMIAL GRAM-NEGATIVE INFECTIONS IN CRITICALLY ILL PATIENTS
    STOUTENBEEK, CP
    VANSAENE, HKF
    ZANDSTRA, DF
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 117 (12) : 458 - 458
  • [47] A Jack of All Trades to Combat Drug-Resistant Gram-Negative Bacteria
    Kodadek, Thomas
    CHEMISTRY & BIOLOGY, 2013, 20 (10): : 1202 - 1203
  • [48] Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation
    Ye, Jing
    Tan, Lin-Hua
    Shen, Zhi-Peng
    Yu, Yun-Song
    Lai, Deng-Ming
    Fan, Jie
    Shu, Qiang
    WORLD JOURNAL OF PEDIATRICS, 2020, 16 (05) : 528 - 532
  • [49] Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation
    Jing Ye
    Lin-Hua Tan
    Zhi-Peng Shen
    Yun-Song Yu
    Deng-Ming Lai
    Jie Fan
    Qiang Shu
    World Journal of Pediatrics, 2020, 16 : 528 - 532
  • [50] Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
    Wang, Peile
    Zhang, Qiwen
    Zhu, Zhenfeng
    Feng, Min
    Sun, Tongwen
    Yang, Jing
    Zhang, Xiaojian
    FRONTIERS IN PHARMACOLOGY, 2020, 11